DexCom (DXCM) Misses Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
DexCom (DXCM) Reports Revenue In-Line with Pre-Release; Piper Jaffray Reiterates Overweight
November 5, 2015 9:53 AM ESTPiper Jaffray reiterated an Overweight rating on DexCom (NASDAQ: DXCM), and raised the price target to $107.00 (from $103.00), following the company's 3Q15 earnings report. DXCM reported revenue of $105.2M, in-line with its pre-release on October 15. 3Q results do not include $800K of revenue deferrals to 4Q related to... More



